Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
Healthcare Antibiotic Resistance Prevalence - DC (HARP-DC): A Regional Prevalence Assessment of Carbapenem-Resistant Enterobacteriaceae (CRE) in Healthcare Facilities in Washington, District of Columbia. MedStar authors:
- Wortmann Glenn W
- Yochelson, Michael
Year: 2017
Citation: - Infection Control & Hospital Epidemiology. 38(8):921-929, 2017 Aug
Institution:
- MedStar National Rehabilitation Network
- MedStar Washington Hospital Center
Department: - Medicine/Infectious Diseases
Medline publication type:
All authors: - Blaylock M, Browne A, Clagon S, DeBiasi R, Dockery B, Donegan N, Hansen K, Harmon K, HARP Study Team, Harris JE, Hooker J, Iyengar P, Jernigan G, Kumar P, Little G, McFadden M, Mirdamadi J, Nelson JA, Reuben J, Sinatro B, Song X, Wagner T, Walker M, White D, Wortmann G, Yochelson M
|
|
8.
|
Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study. MedStar authors:
Year: 2012
Citation: - Clinical Infectious Diseases. 54(5):621-9, 2012 Mar 1.
Institution: - MedStar Washington Hospital Center
Department: - Medicine/Pulmonary-Critical Care
Medline publication type:
- Clinical Trial, Phase IV
- Journal Article
- Multicenter Study
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Baruch A, Chastre J, Kollef MH, Kunkel MJ, McGee WT, Niederman MS, Reisman A, Shorr AF, Wunderink RG
|
|
9.
|
|
|
10.
|
|
|
11.
|
Telavancin hospital-acquired pneumonia trials: impact of Gram-negative infections and inadequate Gram-negative coverage on clinical efficacy and all-cause mortality. MedStar authors:
Year: 2015
Citation: - Clinical Infectious Diseases. 61 Suppl 2:S87-93, 2015 Sep 15.
Institution: - MedStar Washington Hospital Center
Department: - Medicine/Pulmonary-Critical Care
Medline publication type:
- Clinical Trial, Phase III
- Journal Article
- Randomized Controlled Trial
- Research Support, Non-U.S. Gov't
All authors: - Barriere SL, Corey GR, Hardin TC, Lacy MK, Luke DR, Nogid B, Shorr AF, Stryjewski ME, Wang W
|
|
12.
|
|
|
13.
|
|